50-106-0651

GPR55 Rabbit anti-Human, Polyclonal, Proteintech

Manufacturer: Proteintech Group Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-106-0651-Each-of-1 In Stock ₹ 44,150.23

50-106-0651 - Each of 1

₹ 44,150.23

In Stock

Quantity

1

Base Price: ₹ 44,150.23

GST (18%): ₹ 7,947.041

Total Price: ₹ 52,097.271

Antigen

GPR55

Classification

Polyclonal

Conjugate

Unconjugated

Gene

GPR55

Gene Alias

G protein coupled receptor 55, GPR55

Host Species

Rabbit

Purification Method

Antigen Affinity Chromatography

Regulatory Status

RUO

Gene ID (Entrez)

9290

Content And Storage

-20°C

Form

Liquid

Applications

Immunohistochemistry (Paraffin)

Concentration

0.21 mg/mL

Formulation

PBS with 50% glycerol and 0.02% sodium azide; pH 7.3

Gene Accession No.

Q9Y2T6

Gene Symbols

GPR55

Immunogen

Peptide

Quantity

150 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Proteintech Group Inc

50-172-6216

--

Img

Proteintech Group Inc

50-172-6198

--

Img

Proteintech Group Inc

50-100-2831

--

Img

Proteintech Group Inc

50-172-6152

--

Img

Proteintech Group Inc

50-172-6256

--

Img

Proteintech Group Inc

50-172-6140

--

Img

Proteintech Group Inc

50-172-6117

--

Img

Proteintech Group Inc

50-172-6210

--

Description

  • G-protein Coupled Receptors (GPCRs) comprise one of the largest families of signaling molecules with more thana thousandmembers currently predicted to exist
  • All GPCRs share a structural motif consisting of seven membrane-spanning helices, and exist in both active and inactive forms
  • An array of activating ligands participate in the conformation of GPCRs which leads to signaling via G-proteins and downstream effectors
  • Ongoing studies have also shown the vast series of reactions which participate in the negative regulation of GPCRs
  • This "turn-off" activity has tremendous implications for the physiological action of the cell, and continues to drive pharmacological research for new drug candidates
  • .